Consonance Closes Its Third Healthcare Fund at a $1.35 Billion Hard Cap, 58% Above Its Predecessor, in Under Four Months
Consonance Capital Partners closed its third fund at the $1.35 billion hard cap after just under four months, 58% above the $856 million second fund, with endowments and pensions among its investors.
On 9 October 2026, Consonance Capital Partners announced the final close of Consonance Private Equity III, L.P. at $1.35 billion, the fund's hard cap. The firm said the raise was heavily oversubscribed and took just under four months. The fund focuses on lower and middle market US healthcare companies, through growth equity, buyouts, carve-outs, recapitalisations and special situations, the same approach as its predecessors.
The numbers
The second fund closed at its hard cap of $856 million on 8 April 2020, so by our arithmetic Fund III is $494 million, or about 58%, larger. That is a large step-up for a sector specialist, and it came with a short final close timetable: Fund II closed under three months after its initial close, and Fund III closed after just under four months in the market. The firm said it had strong support from existing limited partners and a select group of new investors. The investor base was described as global and diverse, including endowments and foundations, pension plans and financial institutions. No individual limited partners were named, and the target was not disclosed.
How it compares
Healthcare funds made up a visible share of October's closes. Of the four fund closes we have covered so far this month, two (50% by count) were healthcare funds: Consonance at $1.35 billion and Aphias Capital's $1.05 billion debut fund. Together they total $2.4 billion, or about 22% of the $10.9 billion raised across the four, which also include Spectrum Equity's Fund XI at $2.5 billion and LS Power's Fund VI at $6 billion. Consonance's 58% step-up is larger than Spectrum's 25% over its predecessor, but it comes from a smaller base. Aphias raised a first fund of more than $1.05 billion, and the two healthcare managers pulled similar kinds of investors: pensions, endowments and financial institutions, plus health systems and insurers in Aphias's case, as we set out in our piece on mapping warm paths into each type.
What it means for GPs
This section is our reading. Two healthcare closes in a week, both oversubscribed, suggest that LPs are rewarding managers who combine sector focus with a track record of closing quickly. A manager raising a healthcare fund can use that as evidence of demand, but the lesson is the pace: a fund that closes in under four months leaves less room for a long diligence tail, so the data room, references and reporting pack need to be ready before the first meeting. The announcement does not say what share of the fund came from existing investors, so we cannot say how much of the step-up was repeat capital.
What to watch next
Watch for the first portfolio announcements from Fund III and for whether other healthcare specialists report similar step-ups in the weeks ahead. FundLinx members can see which LPs are backing healthcare managers this quarter.
FundLinx Intelligence | FundLinx.ai
Playbooks, LP moves and compliance notes for emerging managers. Unsubscribe any time.
